Protalix BioTherapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2012 to Q3 2024.
  • Protalix BioTherapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$148K, a 188% decline year-over-year.
  • Protalix BioTherapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$681K, a 62.1% increase year-over-year.
  • Protalix BioTherapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.89M, a 36.9% decline from 2022.
  • Protalix BioTherapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.38M, a 80.6% increase from 2021.
  • Protalix BioTherapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$7.12M, a 22.9% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$681K -$148K -$316K -188% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$365K $155K +$929K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$1.29M $123K +$600K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$1.89M -$811K -$96K -13.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$1.8M $168K +$610K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$2.41M -$774K -$964K -507% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$1.44M -$477K -$61K -14.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$1.38M -$715K +$195K +21.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$1.58M -$442K +$1.87M +80.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$3.45M $190K +$2.27M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$5.72M -$416K +$1.41M +77.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$7.12M -$910K +$1.53M +62.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 -$8.65M -$2.31M -$459K -24.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$8.19M -$2.08M -$165K -8.64% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$8.03M -$1.82M +$1.21M +39.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$9.23M -$2.44M -$533K -27.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$8.7M -$1.86M +$161K +7.99% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$8.86M -$1.91M -$6K -0.32% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$8.86M -$3.03M -$1.3M -74.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$7.56M -$1.91M -$147K -8.34% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-31
Q3 2019 -$7.41M -$2.02M -$435K -27.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 -$6.98M -$1.9M -$186K -10.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$6.79M -$1.73M +$358K +17.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-01
Q4 2018 -$7.15M -$1.76M +$1.96M +52.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-30
Q3 2018 -$9.11M -$1.58M +$2.09M +56.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$11.2M -$1.72M -$13M -115% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $1.77M -$2.09M +$50.7M +96% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 -$48.9M -$3.72M -$9.82M -161% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 -$39.1M -$3.67M -$3.03M -472% Jul 1, 2017 Sep 30, 2017 10-Q/A 2019-03-18
Q2 2017 -$36.1M $11.3M +$12.1M Apr 1, 2017 Jun 30, 2017 10-Q/A 2019-03-18
Q1 2017 -$48.1M -$52.8M -$52.1M -7873% Jan 1, 2017 Mar 31, 2017 10-Q/A 2019-03-18
Q4 2016 $3.99M $6.1M +$6.97M Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 -$2.98M -$642K +$371K +36.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$3.35M -$805K -$206K -34.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$3.15M -$662K +$467K +41.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$3.61M -$871K +$517K +37.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 -$4.13M -$1.01M +$789K +43.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$4.92M -$599K +$73K +10.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$4.99M -$1.13M -$252K -28.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$4.74M -$1.39M -$651K -88.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$4.09M -$1.8M -$1.7M -1667% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$2.39M -$672K -$729K -1279% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$1.66M -$877K -$985K -912% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$674K -$737K Oct 1, 2013 Dec 31, 2013 10-K 2016-03-08
Q3 2013 -$102K -$183K -226% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $57K +$35K +159% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $108K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q3 2012 $81K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $22K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.